Loading...
XHKG
0575
Market cap33mUSD
Aug 21, Last price  
0.89HKD
1D
-1.11%
1Q
34.85%
Jan 2017
-92.46%
Name

Endurance RP Ltd

Chart & performance

D1W1MN
XHKG:0575 chart
P/E
—
P/S
91.26
EPS
—
Div yield, %
—
Shrs. gr., 5y
22.97%
Rev. gr., 5y
-26.30%
Revenues
363k
-49.51%
4,175,0003,684,0006,142,00020,553,0005,332,0004,669,0005,890,0002,670,000-10,000212,000137,0005,232,0006,120,000628,0001,670,0003,254,000114,000382,000719,000363,000
Net income
-5m
L+5.09%
8,134,000612,000-160,943,00011,052,00059,792,000-48,527,000-44,854,000-25,636,000-8,563,000-9,333,000-2,460,000-27,359,000-31,087,000-65,999,000-24,396,000-12,598,000-36,427,000-25,049,000-4,482,000-4,710,000
CFO
-4m
L+4.25%
-7,297,000-4,430,000-41,095,000-15,219,000-36,407,000-73,587,000-6,130,00052,654,000-3,984,000-7,732,000-8,307,000-2,747,000-1,882,000-9,038,000-5,721,000-1,703,000506,000-3,590,000-4,129,000-4,304,357
Dividend
Feb 08, 20130.0007 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Regent Pacific Group Limited is an investment holding company that primarily focuses on the healthcare and life sciences sectors. The company is involved in the research, development, and sale of pharmaceutical products, with a notable focus on treatments for urological disorders. It also invests in a portfolio of both listed and unlisted corporate entities.
URL
http://www.endurancerp.com/
IPO date
May 19, 1997
Employees
20
Domiciled in
HK
Incorporated in
KY

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT